|
|
|
|
| LEADER |
01000naa a22002652 4500 |
| 001 |
NLM286887746 |
| 003 |
DE-627 |
| 005 |
20231225052749.0 |
| 007 |
cr uuu---uuuuu |
| 008 |
231225s2018 xx |||||o 00| ||eng c |
| 024 |
7 |
|
|a 10.1016/j.clim.2018.07.012
|2 doi
|
| 028 |
5 |
2 |
|a pubmed24n0956.xml
|
| 035 |
|
|
|a (DE-627)NLM286887746
|
| 035 |
|
|
|a (NLM)30048690
|
| 035 |
|
|
|a (PII)S1521-6616(18)30220-1
|
| 040 |
|
|
|a DE-627
|b ger
|c DE-627
|e rakwb
|
| 041 |
|
|
|a eng
|
| 100 |
1 |
|
|a Hoshino, Akihiro
|e verfasserin
|4 aut
|
| 245 |
1 |
0 |
|a High frequencies of asymptomatic Epstein-Barr virus viremia in affected and unaffected individuals with CTLA4 mutations
|
| 264 |
|
1 |
|c 2018
|
| 336 |
|
|
|a Text
|b txt
|2 rdacontent
|
| 337 |
|
|
|a ƒaComputermedien
|b c
|2 rdamedia
|
| 338 |
|
|
|a ƒa Online-Ressource
|b cr
|2 rdacarrier
|
| 500 |
|
|
|a Date Completed 27.08.2019
|
| 500 |
|
|
|a Date Revised 27.08.2019
|
| 500 |
|
|
|a published: Print-Electronic
|
| 500 |
|
|
|a Citation Status MEDLINE
|
| 520 |
|
|
|a Copyright © 2018 Elsevier Inc. All rights reserved.
|
| 520 |
|
|
|a Patients with CTLA4 mutations present with autoimmune diseases, lymphoproliferation, and hypogammaglobulinemia, and a subset of patients developed Epstein-Barr virus (EBV)-associated malignancies, suggesting an impaired immune function against EBV. Here we investigated EBV infection in individuals with CTLA4 mutations. We measured EBV viral DNA in healthy individuals, individuals with autoimmune diseases, and individuals with CTLA4 mutations. In addition, we evaluated the numbers and function of EBV-specific T cells, invariant NKT cells, and NK cells. More than half of individuals with CTLA4 mutations including asymptomatic ones had detectable EBV DNA, which is a significantly higher frequency with higher viral loads compared with healthy and disease controls. However, individuals with CTLA4 mutations had almost normal immunity against EBV. Individuals with CTLA4 mutations have an increased susceptibility to Epstein-Barr virus infections. Asymptomatic viremia occurs at high frequencies, which can be persistent and can occur in unaffected individuals
|
| 650 |
|
4 |
|a Journal Article
|
| 650 |
|
4 |
|a Research Support, Non-U.S. Gov't
|
| 650 |
|
4 |
|a Asymptomatic viremia
|
| 650 |
|
4 |
|a CTLA4 deficiency
|
| 650 |
|
4 |
|a Epstein–Barr virus
|
| 650 |
|
7 |
|a CTLA-4 Antigen
|2 NLM
|
| 650 |
|
7 |
|a CTLA4 protein, human
|2 NLM
|
| 650 |
|
7 |
|a DNA, Viral
|2 NLM
|
| 700 |
1 |
|
|a Tanita, Kay
|e verfasserin
|4 aut
|
| 700 |
1 |
|
|a Kanda, Kenji
|e verfasserin
|4 aut
|
| 700 |
1 |
|
|a Imadome, Ken-Ichi
|e verfasserin
|4 aut
|
| 700 |
1 |
|
|a Shikama, Yoshiaki
|e verfasserin
|4 aut
|
| 700 |
1 |
|
|a Yasumi, Takahiro
|e verfasserin
|4 aut
|
| 700 |
1 |
|
|a Imai, Kohsuke
|e verfasserin
|4 aut
|
| 700 |
1 |
|
|a Takagi, Masatoshi
|e verfasserin
|4 aut
|
| 700 |
1 |
|
|a Morio, Tomohiro
|e verfasserin
|4 aut
|
| 700 |
1 |
|
|a Kanegane, Hirokazu
|e verfasserin
|4 aut
|
| 773 |
0 |
8 |
|i Enthalten in
|t Clinical immunology (Orlando, Fla.)
|d 1999
|g 195(2018) vom: 15. Okt., Seite 45-48
|w (DE-627)NLM098196855
|x 1521-7035
|7 nnns
|
| 773 |
1 |
8 |
|g volume:195
|g year:2018
|g day:15
|g month:10
|g pages:45-48
|
| 856 |
4 |
0 |
|u http://dx.doi.org/10.1016/j.clim.2018.07.012
|3 Volltext
|
| 912 |
|
|
|a GBV_USEFLAG_A
|
| 912 |
|
|
|a SYSFLAG_A
|
| 912 |
|
|
|a GBV_NLM
|
| 912 |
|
|
|a GBV_ILN_11
|
| 912 |
|
|
|a GBV_ILN_24
|
| 912 |
|
|
|a GBV_ILN_350
|
| 951 |
|
|
|a AR
|
| 952 |
|
|
|d 195
|j 2018
|b 15
|c 10
|h 45-48
|